Compare AXSM & STEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXSM | STEP |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2015 | 2020 |
| Metric | AXSM | STEP |
|---|---|---|
| Price | $149.29 | $62.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 7 |
| Target Price | ★ $176.00 | $74.29 |
| AVG Volume (30 Days) | 551.7K | ★ 688.9K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $561,263,000.00 | ★ $1,535,264,000.00 |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | $30.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 65.83 | ★ 91.84 |
| 52 Week Low | $75.56 | $40.07 |
| 52 Week High | $152.94 | $68.41 |
| Indicator | AXSM | STEP |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 51.39 |
| Support Level | $141.69 | $60.77 |
| Resistance Level | $151.63 | $63.92 |
| Average True Range (ATR) | 4.61 | 1.86 |
| MACD | -0.59 | 0.19 |
| Stochastic Oscillator | 67.13 | 65.49 |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.